論文（邦文）
- 血尿(特発性腎出血を含む)
- 杉元幹史
今日の治療指針 Vol.66 医学書院 p1250 – 1251
- 国民のための名医ランキング
- 杉元幹史
桜の花出版 p358
- 泌尿器科的エマージェンシー
- 田岡利宜也
新臨床腫瘍学（改訂第7版） 南江堂 p662-664
- 抗悪性腫瘍薬（ホルモン療法薬－前立腺癌）
- 田岡利宜也, 筧善行
Pocket Drugs 2024 医学書院 p598-602
- 臨床腎・泌尿器癌(中) -基礎・臨床研究の進歩- Ⅲ.膀胱癌の診断・マーカー 筋層浸潤性膀胱癌のリスク分類
- 田岡利宜也, 杉元幹史
日本臨牀82巻増刊号9 日本臨牀社 p109-113
- 「日本泌尿器腫瘍学会 第10回学術集会」 印象記
- 田岡利宜也
臨床泌尿器科12月号 医学書院 in press
- 低リスク前立腺癌の治療をめぐって
- 土肥洋一郎, 加藤琢磨, 杉元幹史
UrologyToday vol.30 No.2 2023 RichHill Medical Inc.
- 慢性前立腺炎診断ツール確立プロジェクト 慢性前立腺炎の新規診断支援ツールの開発に向けて
- 土肥洋一郎, 杉元幹史
Precision medicine 2024年5月号 北隆館
- 前立腺の炎症と前立腺肥大症の関係
- 土肥洋一郎, 杉元幹史
Prostate journal vol11 No.2 October 2024 医学図書出版
論文（英文）
- Usefulness of fluorescent ureteral catheter during laparoscopic residual ureterectomy
- Tomoko Honda, Yuki Matsuoka, Yu Osaki, Yoichiro Tohi, Hirohito Naito, Takuma Kato, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto
IJU Case Rep. 2023 Dec 19;7(2):120-122. doi: 10.1002/iju5.12680. eCollection 2024 Mar.
- Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
- Yoichiro Tohi, Takuma Kato, Keita Kobayashi, Kei Daizumoto, Hideo Fukuhara, Shin Ohira, Satoshi Katayama, Ryutaro Shimizu, Atsushi Takamoto, Kenichi Nishimura, Kenichiro Ikeda, Taichi Nagami, Yushi Hayashida, Hiromi Hirama, Hirohito Naito, Ryotaro Tomida, Yutaro Sasaki, Shinkuro Yamamoto,ShinjiroShimizu,Mikio Sugimoto, Chu-shikoku Japan Urological Consortium
Jpn J Clin Oncol. 2024 Feb 7;54(2):167-174. doi: 10.1093/jjco/hyad143.
- Successful laparoscopic retroperitoneal tumor resection using mixed reality and guiding marker techniques
- Yoichiro Tohi, Homare Okazoe, Katsuya Mitamura, Yu Osaki, Kenichi Tanaka, Yuki Matsuoka, Yoshihiro Nishiyama, Kenji Kanenishi, Mikio Sugimoto
IJU Case Rep. 2024 Jun 3;7(4):320-323. doi: 10.1002/iju5.12735. eCollection 2024 Jul.
- Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry
- Chris Bangma, Paul Doan, Lin Zhu, Sebastiaan Remmers, Daan Nieboer, Jozien Helleman, Monique J Roobol, Mikio Sugimoto, Byung Ha Chung, Lui Shiong Lee, Mark Frydenberg, Laurence Klotz, Michael Peacock, Antoinette Perry, Anders Bjartell, Antti Rannikko, Mieke Van Hemelrijck, Prokar Dasgupta, Caroline Moore, Bruce J Trock, Christian Pavlovich , Ewout Steyerberg, Peter Carroll, Kyo Chul Koo, Andrew Hayen, James Thompson
Eur Urol Oncol. 2024 Jul 17:S2588-9311(24)00176-7. doi: 10.1016/j.euo.2024.07.003. Online ahead of print.
- A surgical checklist for optimizing the quality and outcomes of transurethral resection of bladder tumors: A literature review
- Rikiya Taoka, Mikio Sugimoto
Int J Urol. 2024 Aug;31(8):846-851. doi: 10.1111/iju.15480. Epub 2024 May 3.
- Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
- Noel W Clarke, Andrew J Armstrong, Mototsugu Oya, Neal Shore, Giuseppe Procopio, João Daniel Guedes, Cagatay Arslan, Niven Mehra, Francis Parnis, Emma Brown, Friederike Schlürmann, Jae Young Joung, Mikio Sugimoto, Oliver Sartor, Christian Poehlein, David McGuinness, Arnold Degboe, Fred Saad
Eur Urol Oncol. 2024 Oct 8:S2588-9311(24)00222-0. doi: 10.1016/j.euo.2024.09.013. Online ahead of print.
- Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan
- Takuma Kato, Hiromi Hirama, Toshiyuki Kamoto, Takayuki Goto, Hiroyuki Fujimoto, Shinichi Sakamoto, Nobuo Shinohara, Shin Egawa, Dai Kouguchi, Masashi Nakayama, Katsuyoshi Hashine, Nobuaki Shimizu, Koji Inoue, Tomonori Habuchi, Takaya Hioka, Taizou Shiraishi, Mikio Sugimoto, Yoshiyuki Kakehi
Int J Clin Oncol. 2024 Oct;29(10):1557-1563. doi: 10.1007/s10147-024-02590-4. Epub 2024 Aug 1
- Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial
- Rikiya Taoka, Hideo Fukuhara, Makito Miyake, Keita Kobayashi, Atsushi Ikeda, Kent Kanao , Yoshinobu Komai, Ryo Fujiwara, Yusuke Sato, Mikio Sugimoto, Toyonori Tsuzuki, Kiyohide Fujimoto , Keiji Inoue, Mototsugu Oya
Int J Clin Oncol. 2024 Nov 19 doi: 10.1007/s10147-024-02654-5. Online ahead of print.
- Japanese clinical practice guidelines for prostate cancer 2023
- Yasuo Kohjimoto, Hiroji Uemura, Masahiro Yoshida, Shiro Hinotsu, Satoru Takahashi, Tsutomu Takeuchi, Kazuhiro Suzuki, Hiroshi Shinmoto, Tsutomu Tamada, Takahiro Inoue, Mikio Sugimoto, Atsushi Takenaka, Tomonori Habuchi, Hitoshi Ishikawa, Takashi Mizowaki, Shiro Saito, Hideaki Miyake, Nobuaki Matsubara, Norio Nonomura, Hideki Sakai, Akihiro Ito, Osamu Ukimura, Hideyasu Matsuyama, Isao Hara
Int J Urol. 2024 Nov;31(11):1180-1222. doi: 10.1111/iju.15545. Epub 2024 Jul 30.
- Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-institutional study in Japan
- Shuichi Morizane, Keita Nakane, Toshiaki Tanaka, Kenji Zennami, Kentaro Muraoka, Shin Ebara, Noriyoshi Miura, Koichi Uemura, Ryuta Sobu, Akio Hoshi, Rikiya Taoka, Mikio Sugimoto, Hisashi Noma, Hiroshi Sunada, Hiroyuki Nishiyama, Tomonori Habuchi, Ichiro Ikeda, Takashi Saika, Kazuhide Makiyama, Ryoichi Shiroki, Naoya Masumori, Takuya Koie, Atsushi Takenaka
Int J Clin Oncol. 2024 Jan;29(1):64-71.
- Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study
- Taoka R, Kamada M, Izumi K, Tanimoto R, Daizumoto K, Hayashida Y, Uematsu K, Arai H, Sano T, Saito R, Hirama H, Kobayashi T, Honda T, Osaki Y, Abe Y, Naito H, Tohi Y, Matsuoka Y, Kato T, Okazoe H, Ueda N, Sugimoto M.
Int J Clin Oncol. 29(5):602-611. doi: 10.1007/s10147-024-02481-8. Epub 2024 Feb
- The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy
- Kikuchi H, Abe T, Miyake M, Miyata H, Matsumoto R, Osawa T, Nishimura N, Fujimoto K, Inokuchi J, Yoneyama T, Tomida R, Numakura K, Matsushita Y, Matsumoto K, Sato T, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Shinohara N.
Jpn J Clin Oncol. 2024 Feb 7;54(2):192-200.
- Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis
- Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Okajima E, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K
World J Urol. 2024 Mar 21;42(1):185.
- Editorial Comment on Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy
- Taoka R, Sugimoto M
Int J Urol. 2024 Apr;31(4):418-419.
- Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection
- Li R, Hensley PJ, Gupta S, Al-Ahmadie H, Babjuk M, Black PC, Brausi M, Bree KK, Fernández MI, Guo CC, Horowitz A, Lamm DL, Lerner SP, Lotan Y, Mariappan P, McConkey D, Mertens LS, Mir C, Ross JS, O'Donnell M, Palou J, Pohar K, Steinberg G, Soloway M, Spiess PE, Svatek RS, Tan WS, Taoka R, Buckley R, Kamat AM.
Eur Urol. 2024 Aug 24:S0302-2838(24)02516-8.
- Prognostic impact of histological discordance between transurethral resection and radical cystectomy
- Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y
BJU Int. 2024 Aug;134(2):207-218.
- Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer
- Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T
Int J Urol. 2024 Sep 18. doi: 10.1111/iju.15585. Online ahead of print.
- Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study
- Miki J, Fukuokaya W, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T
Int J Urol. 2024 Sep;31(9):1009-1016.
- Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial
- Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M.
Int J Clin Oncol. 2024 Oct 7. doi: 10.1007/s10147-024-02638-5. Online ahead of print.
- Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer:a nationwide multicenter study
- Kato M, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Yamamoto S, Matsue T, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Uchida J
Int J Clin Oncol. 2024 Oct 9. doi: 10.1007/s10147-024-02636-7. Online ahead of print.
- Phase 3 THOR Japanese subgroup analysis: erdafitinib in advanced or metastatic urothelial cancer and fibroblast growth factor receptor alterations
- Matsubara N, Miura Y, Nishiyama H, Taoka R, Kojima T, Shimizu N, Hwang J, Ote T, Oyama R, Toyoizumi K, Mukhopadhyay S, Triantos S, Deprince K, Loriot Y
Int J Clin Oncol. 2024 Oct;29(10):1516-1527.
- Chloride Ion Transport Blockade Enhances the Cytocidal Effects of Sterile Water on Bladder Cancer Cells
- Yuki Matsuoka, Rikiya Taoka*, Yoichiro Tohi, Xia Zhang, Mikio Sugimoto
Journal of Cancer Science and Clinical Therapeutics 7(4):271-276,2023
- Accuracy of photodynamic diagnosis for non-muscle-invasive bladder cancer: exploratory analysis of anatomical locations and tumor types using data from a prospective, single-arm, multicenter phase III trial
- Rikiya Taoka, Kiyohide Fujimoto, Keiji Inoue, Toyonori Tsuzuki, Mototsugu Oya, Mikio Sugimoto
Int J Urol. in press
- Three-Year Outcomes of a Multicenter Study of Japanese-Style Laparoscopic Sacrocolpopexy
- Tomoko Kuwata, Hiromi Kashihara, Chikako Kato, Masami Takeyama, Akane Yamaguchi, Youji Moriyama, Chie Nakai, Kosei Miwa, Hidemori Araki, Masahiro Narushima, Mari Yamasaki, Hiromi Hirama, Homare Okazoe.
Int Urogynecol J. Published online 2024 Oct. 29
- Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN)
- Takuma Kato, Ryuji Matsumoto, Akira Yokomizo, Yoichiro Tohi, Hiroshi Fukuhara, Yoichi Fujii, Keiichiro Mori, Takuma Sato, Junichi Inokuchi, Katsuyoshi Hashine, Shinichi Sakamoto, Hidefumi Kinoshita, Koji Inoue, Toshiki Tanikawa, Takanobu Utsumi, Takayuki Goto, Isao Hara, Hiroshi Okuno, Yoshiyuki Kakehi, Mikio Sugimoto
BJU Int 2024 Oct;134(4):652-658. doi: 10.1111/bju.16436.
- How widespread is active surveillance of early-stage prostate cancer in Japan? Multicenter questionnaire survey on the status of active surveillance of early-stage prostate cancer in Japan.
- Kato T, Tohi Y, Okazoe H, Taoka R, Ueda N, Sugimoto M
Int J Urol. 2024 Sep 4. doi: 10.1111/iju.15573. Online ahead of print. PMID: 39231791
- Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan.
- Kato T, Hirama H, Kamoto T, Goto T, Fujimoto H, Sakamoto S, Shinohara N, Egawa S, Kouguchi D, Nakayama M, Hashine K, Shimizu N, Inoue K, Habuchi T, Hioka T, Shiraishi T, Sugimoto M, Kakehi Y
Int J Clin Oncol. 2024 Aug 1. doi: 10.1007/s10147-024-02590-4. Online ahead of print. PMID: 39085727
- Prognostication in lymph node-positive prostate cancer with no PSA persistence after radical prostatectomy
- Masaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, Akira Yokomizo, Shuichi Morizane, Ryoichi Saito, Makito Miyake, Masakazu Tsutsumi, Yoshiyuki Yamamoto, Kojiro Tashiro, Ryotaro Tomida, Shintaro Narita, Kohei Edamura, Takahiro Yamaguchi, Kohei Hashimoto, Masashi Kato, Takashi Kasahara, Takayuki Yoshino, Shusuke Akamatsu, Tomoyuki Kaneko, Akihiro Matsukawa, Ryuji Matsumoto, Akira Joraku, Toshihiro Saito, Takuma Kato, Manabu Kato, Hideki Enokida, Shinichi Sakamoto, Naoki Terada, Hidenori Kanno, Naotaka Nishiyama, Takahiro Kimura, Hiroshi Kitamura, Masatoshi Eto; Japanese Urological Oncology Group
Ann Surg Oncol. 2024 Jun;31(6):3872-3879. doi: 10.1245/s10434-024-14999-2.
- PSA Doubling Time 4.65 months as an Optimal Cut-off of Japanese Nonmetastatic Castration-Resistant Prostate Cancer
- Shinichi Sakamoto, Kodai Sato, Takahiro Kimura, Yoshiyuki Matsui, Yusuke Shiraishi, Kohei Hashimoto, Hideaki Miyake, Shintaro Narita, Jun Miki, Ryuji Matsumoto, Takuma Kato, Toshihiro Saito, Masaki Tomida, Masaki Shiota, Jyoraku Akira, Naoki Terada, Suekane Shigetaka, Toru Nakagawa, Hideki Enokida, Yuko Yoshio, Yoshino Takayuki, Naotaka Nishiyama, Tomohiko Ichikawa, Hiroshi Kitamura and Japan Urology Oncology Group
Sci Rep. 2024 Jul 3;14(1):15307. doi: 10.1038/s41598-024-65969-3.
- Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study
- Tomokazu Sazuka, Yuto Matsushita, Hiroaki Sato, Takahiro Osawa, Nobuyuki Hinata, Shingo Hatakeyama, Kazuyuki Numakura, Kosuke Ueda, Takahiro Kimura, Masayuki Takahashi, Hajime Tanaka, Akihiro Ito, Toshifumi Kurahashi, Takuma Kato, Kazutoshi Fujita, Makito Miyake, Takahiro Kojima, Hiroshi Kitamura, Hideaki Miyake, Tomohiko Ichikawa
Sci Rep. 2023 Nov 23;13(1):20629. doi: 10.1038/s41598-023-48087-4.
- Impact of frailty on cancer-related fatigue and quality of life in outpatients with prostate cancer: a cross-sectional study of patient-reported outcomes.
- Tohi Y, Kato T, Honda T, Osaki Y, Abe Y, Naito H, Matsuoka Y, Okazoe H, Taoka R, Ueda N, Sugimoto M
Jpn J Clin Oncol. 2024 Jun 1;54(6):708-715.
- Impact of the coronavirus disease pandemic on robot-assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study.
- Tohi Y, Osaki Y, Kato T, Honda T, Abe Y, Naito H, Matsuoka Y, Okazoe H, Taoka R, Ueda N, Sugimoto M
Int J Urol. 2024 Aug;31(8):899-905.
- Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium.
- Tohi Y, Sahrmann JM, Arbet J, Kato T, Lee LS, Peacock M, Ginsburg K, Pavlovich C, Carroll P, Bangma CH, Sugimoto M, Boutros PC
Eur Urol Oncol. 2024 Jul 31 S2588-9311(24)00179-2.
- Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer.
- Hattori Y, Fujiwara T, Hagimoto H, Kokubun H, Murata S, Makita N, Abe Y, Kubota M, Tohi Y, Tsutsumi N, Shibasaki N, Inoue K, Kawakita M, Yamasaki T
Int J Urol. 2024 Oct;31(10):1102-1106.
- A narrative review of optimal treatment choices in robot-assisted partial nephrectomy focusing on indication and surgical procedure.
- Naito H, Tohi Y, Sugimoto M
AME Med J 2024.doi: 10.21037/amj-23-233
- Double somatic mutations in CTNNB1 and GNA11 in an aldosterone-producing adenoma
- Kazutaka Nanba, Amy R Blinder, Aaron M Udager, Yuusuke Hirokawa, Takayoshi Miura, Hiroshi Okuno, Koki Moriyoshi, Yuto Yamazaki, Hironobu Sasano, Akihiro Yasoda, Noriko Satoh-Asahara, William E Rainey, Tetsuya Tagami
Front Endocrinol (Lausanne). 2024 Mar 5
- Case report: Para-testicular spindle cell lipoma suspected of well-differentiated liposarcoma
- Kengo Fujiwara, Kengo Fujimoto, Emi Ibuki, Ryo Ishikawa, Yushi Hayashida.
